To enhance the patient experience, we provide a comprehensive peptide administration kit, which includes all necessary supplies for safe and effective use
Clinical evidence indicates they may slow the progression of diabetic kidney disease, preserving renal health over the long term
While there is no medically mandated best time that applies universally, many providers recommend taking your first injection in the morning or shortly after a meal
In March 2026, topline results from the TRANSCEND-T2D-1 trials showed that participants with Type 2 diabetes achieved an average A1C reduction of up to 2.0% and lost nearly 17% of their body weight over 40 weeks
The combination of GLP-1, GIP, and glucagon receptor activation produces complex effects on blood glucose
Summary Pulling the new reports together, there is further momentum and excitement building for GLP-1 drug expanded use beyond diabetes and obesity